655 reports of this reaction
2.5% of all LEVODOPA reports
#8 most reported adverse reaction
DEVICE ISSUE is the #8 most commonly reported adverse reaction for LEVODOPA, manufactured by Merz Pharmaceuticals, LLC. There are 655 FDA adverse event reports linking LEVODOPA to DEVICE ISSUE. This represents approximately 2.5% of all 26,727 adverse event reports for this drug.
Patients taking LEVODOPA who experience device issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEVICE ISSUE is a less commonly reported adverse event for LEVODOPA, but still significant enough to appear in the safety profile.
In addition to device issue, the following adverse reactions have been reported for LEVODOPA:
The following drugs have also been linked to device issue in FDA adverse event reports:
DEVICE ISSUE has been reported as an adverse event in 655 FDA reports for LEVODOPA. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEVICE ISSUE accounts for approximately 2.5% of all adverse event reports for LEVODOPA, making it a notable side effect.
If you experience device issue while taking LEVODOPA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.